LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY

Kuemmerle-Deschner JB, Kortus-Goetze B, Oommen P, Janda A, Rech J, Kallinich T, Weller-Heinemann F, Horneff G, Foeldvari I, Schuetz C, Borte M, Braner A, Weber-Arden J, Blank N (2021)

Publication Type: Conference contribution

Publication year: 2021

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 50-51

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2021-eular.3716

Authors with CRIS profile

Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology

Involved external institutions

Universitätsklinikum Tübingen

Germany (DE) Philipps-Universität Marburg

Germany (DE) Universitätsklinikum Frankfurt am Main (KGU)

Germany (DE) Heinrich-Heine-Universität Düsseldorf

Germany (DE) Asklepios Kliniken

Germany (DE) Klinikverbund Bremen (Gesundheit Nord)

Germany (DE) Klinikum St. Georg

Germany (DE) Technische Universität Dresden

Germany (DE) Novartis AG

Switzerland (CH) Universitätsklinikum Ulm

Germany (DE) Charité - Universitätsmedizin Berlin

Germany (DE) Universitätsklinikum Heidelberg

Germany (DE)

How to cite

APA:

Kuemmerle-Deschner, J.B., Kortus-Goetze, B., Oommen, P., Janda, A., Rech, J., Kallinich, T.,... Blank, N. (2021). LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY. In ANNALS OF THE RHEUMATIC DISEASES (pp. 50-51). LONDON: BMJ PUBLISHING GROUP.

MLA:

Kuemmerle-Deschner, J. B., et al. "LONG-TERM SAFETY AND EFFECTIVENESS OF CANAKINUMAB IN CRYOPYRIN-ASSOCIATED PERIODIC SYNDROMES (CAPS)-30-MONTH DATA FROM THE RELIANCE REGISTRY." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2021. 50-51.

BibTeX: Download